Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (421-430 of 1,211) with videos related to

Pageof 122
Sort By:
Journal of the American Heart Association|October 29, 2021
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC StudyWendy Wang, Faye L Norby, Michael J Zhang, et al.
Nature Medicine|May 6, 2024
A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trialsToru Kondo, Pardeep S Jhund, Samvel B Gasparyan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2011
Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trialEldrin F Lewis, Marc A Pfeffer, Amy Feng, et al.
Circulation. Heart Failure|April 9, 2016
Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection FractionAngela B S Santos, Gabriela Querejeta Roca, Brian Claggett, et al.
Journal of the American College of Cardiology|January 28, 2022
Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart FailureAlvin Chandra, Hicham Skali, Brian Claggett, et al.
Circulation|February 24, 2010
Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or bothSung-Hee Shin, Chung-Lieh Hung, Hajime Uno, et al.
Circulation. Heart Failure|January 21, 2020
Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction: A TOPCAT Biorepository StudyPeder L Myhre, Muthiah Vaduganathan, Eileen O'Meara, et al.
ESC Heart Failure|October 20, 2020
Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HFSu E Yeoh, Pooja Dewan, Akshay S Desai, et al.
Clinical Chemistry|January 8, 2021
High-Sensitivity Cardiac Troponin, Natriuretic Peptide, and Long-Term Risk of Acute Kidney Injury: The Atherosclerosis Risk in Communities (ARIC) StudyJunichi Ishigami, Yuhree Kim, Yingying Sang, et al.
JAMA Cardiology|December 8, 2022
Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure: A Secondary Analysis of the PARADIGM-HF TrialLuis E Rohde, André Zimerman, Muthiah Vaduganathan, et al.
Pageof 122

Showing results (421-430 of 1,211) with videos related to

Sort By:
Pageof 122
Journal of the American Heart Association|October 29, 2021
Differences in Left Atrial Size and Function and Supraventricular Ectopy Between Black and White Participants in the ARIC StudyWendy Wang, Faye L Norby, Michael J Zhang, et al.
Nature Medicine|May 6, 2024
A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trialsToru Kondo, Pardeep S Jhund, Samvel B Gasparyan, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2011
Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trialEldrin F Lewis, Marc A Pfeffer, Amy Feng, et al.
Circulation. Heart Failure|April 9, 2016
Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection FractionAngela B S Santos, Gabriela Querejeta Roca, Brian Claggett, et al.
Journal of the American College of Cardiology|January 28, 2022
Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart FailureAlvin Chandra, Hicham Skali, Brian Claggett, et al.
Circulation|February 24, 2010
Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or bothSung-Hee Shin, Chung-Lieh Hung, Hajime Uno, et al.
Circulation. Heart Failure|January 21, 2020
Mechanistic Effects of Spironolactone on Cardiovascular and Renal Biomarkers in Heart Failure With Preserved Ejection Fraction: A TOPCAT Biorepository StudyPeder L Myhre, Muthiah Vaduganathan, Eileen O'Meara, et al.
ESC Heart Failure|October 20, 2020
Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HFSu E Yeoh, Pooja Dewan, Akshay S Desai, et al.
Clinical Chemistry|January 8, 2021
High-Sensitivity Cardiac Troponin, Natriuretic Peptide, and Long-Term Risk of Acute Kidney Injury: The Atherosclerosis Risk in Communities (ARIC) StudyJunichi Ishigami, Yuhree Kim, Yingying Sang, et al.
JAMA Cardiology|December 8, 2022
Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure: A Secondary Analysis of the PARADIGM-HF TrialLuis E Rohde, André Zimerman, Muthiah Vaduganathan, et al.
Pageof 122